Patricia Mester, Pablo Amend, Stephan Schmid, Jürgen J. Wenzel, Marcus Höring, Gerhard Liebisch, . . . Vlad Pavel. (2024). Proprotein Convertase Subtilisin/Kexin Type 9 Induction in COVID-19 Is Poorly Associated with Disease Severity and Cholesterol Levels. MDPI AG.
Chicago Style (17th ed.) CitationPatricia Mester, et al. Proprotein Convertase Subtilisin/Kexin Type 9 Induction in COVID-19 Is Poorly Associated with Disease Severity and Cholesterol Levels. MDPI AG, 2024.
MLA (9th ed.) CitationPatricia Mester, et al. Proprotein Convertase Subtilisin/Kexin Type 9 Induction in COVID-19 Is Poorly Associated with Disease Severity and Cholesterol Levels. MDPI AG, 2024.
Warning: These citations may not always be 100% accurate.